Sentinel Node Imaging and Radioguided Surgery in the Era of SPECT/CT and PET/CT: Toward New Interventional Nuclear Medicine Strategies.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
pubmed:
24
7
2020
medline:
11
11
2020
entrez:
24
7
2020
Statut:
ppublish
Résumé
We review recent technological advances and new clinical indications for sentinel node (SN) and radioguided surgery in order to delineate future tendencies of interventional nuclear medicine in this field. A literature research was performed in PubMed to select relevant articles to be used as key references for analysis of the current approaches and tendencies in SN and radioguided surgery, as well as the evolving contribution of nuclear medicine intervention techniques to the various clinical applications. For classic indications such as melanoma and breast cancer, the incorporation of the SN approach based on the combined use of existing and new preoperative and intraoperative technologies in high-risk patient categories is becoming an emerging area of clinical indication. For SN biopsy staging in other malignancies with more complex lymphatic drainage, the incorporation of sophisticated tools is most helpful. The consecutive use of PET/CT and the SN procedure is increasing as a potential combined approach for the management of specific areas such as the axilla and the pelvis in patients at high risk of regional dissemination. Also, for the management of locoregional metastasis and oligometastatic disease, interventional nuclear medicine techniques are becoming valuable alternatives. The extended experience with SN biopsy is leading to technological advances facilitating the incorporation of this procedure to stage other malignancies with complex lymphatic drainage. New nuclear medicine-based approaches, incorporating SPECT/CT and PET/CT to guide resection of SNs and occult metastases, have recently been gaining ground.
Identifiants
pubmed: 32701805
doi: 10.1097/RLU.0000000000003206
pii: 00003072-202010000-00005
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
771-777Références
Valdés Olmos RA, Orsini F, Giammarile F, et al. Radioguided surgery: novel applications. In: Strauss HW, Mariani G, Volterrani D, et al., eds. Nuclear Oncology, From Pathophysiology to Clinical Applications. Basel, Switzerland: Springer; 2017:1451–2303.
Zaknum JJ, Giammarile F, Valdés Olmos R, et al. Changing paradigms in radioguided surgery and intraoperative imaging: the GOSTT concept. Eur J Nucl Med Mol Imaging. 2012;39:1–3.
Valdés Olmos RA, Vidal-Sicart S, Manca G, et al. Advances in radioguided surgery in oncology. Q J Nucl Med Mol Imaging. 2017;61:247–270.
Ballinger J. The use of protein-based radiocolloids in sentinel node localisation. Clin Transl Imaging. 2015;3:179–186.
Paganelli G, Luini A, Sansovini M, et al. Development of sentinel node localization and ROLL in breast cancer in Europe. Clin Transl Imaging. 2015;3:171–178.
Pouw B, de Wit-van der Veen LJ, van der Hage JA, et al. Heading toward radioactive seed localization in non-palpable breast cancer surgery? A meta-analysis. J Surg Oncol. 2015;111:185–191.
Ahmed M, Douek M. Sentinel node and occult lesion localization (SNOLL): a systematic review. Breast. 2013;22:1034–1040.
Maurer T, Graefen M, van der Poel H, et al. Prostate-specific membrane antigen–guided surgery. J Nucl Med. 2020;61:6–12.
Valdés Olmos RA, Hoefnagel CA, Nieweg OE, et al. Lymphoscintigraphy in oncology: a rediscovered challenge. Eur J Nucl Med. 1999;26:S2–S10.
Valdés Olmos RA, Rietbergen DD, Vidal-Sicart S, et al. Contribution of SPECT/CT imaging to radioguided sentinel lymph node biopsy in breast cancer, melanoma, and other cancers: from “open and see” to “see and open”. Q J Nucl Med Mol Imaging. 2014;58:127–139.
Den Toom IJ, van Schie A, van Weert S, et al. The added value of SPECT/CT for the identification of sentinel lymph nodes in early stage oral cancer. Eur J Nucl Med Mol Imaging. 2017;44:998–1004.
Vidal-Sicart S, Valdés Olmos RA. Sentinel node approach in prostate cancer. Rev Esp Med Nuclear Imagen Mol. 2015;34:358–371.
Hoogendam JP, Veldhuis WB, Hobbelink MG, et al. 99mTc SPECT/CT versus planar lymphoscintigraphy for preoperative sentinel lymph node detection in cervical cancer: a systematic review and metaanalysis. J Nucl Med. 2015;56:675–680.
Jimenez-Hefferman A, Ellman A, Sado H, et al. Results of a prospective multicenter International Atomic Energy Agency sentinel node trial on the value of SPECT/CT over planar imaging in various malignancies. J Nucl Med. 2015;56:1338–1344.
Mueller JJ, Dauer LT, Murali R, et al. Positron lymphography via intracervical 18F-FDG injection for pre-surgical lymphatic mapping in cervical and endometrial malignancies [published online January 10, 2020]. J Nucl Med. 2020.
Zang J, Sui H, Guo H, et al. Combined 68Ga-NOTA-Evans blue lymphoscintigraphy and 68Ga-NOTA-RM26 PET/CT evaluation of sentinel lymph node metastasis in breast cancer metastasis. Bioconjug Chem. 2020;31:396–403.
Ankersmit M, Hoekstra OS, van Lingen A, et al. Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer. Eur J Nucl Med Mol Imaging. 2019;46:1495–1505.
Heuveling DA, Karagozoglu KH, van Lingen A, et al. Feasibility of intraoperative detection of sentinel lymph node with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe. EJNMMI Res. 2018;8:15.
Vidal-Sicart S, Vera DR, Valdés Olmos RA. Next generation of radiotracers for sentinel lymph node biopsy: what is still necessary to establish new imaging paradigms?Rev Esp Med Nucl Imagen Mol. 2018;37:373–379.
Silvestri C, Christopher A, Intenzo C, et al. Consecutive case series of melanoma sentinel node biopsy for Lymphoseek compared to sulfur colloids. J Surg Res. 2019;233:149–153.
Unkart JT, Proudfoot J, Wallace AM. Outcomes of “one-day” vs “two-day” injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer. Breast J. 2018;24:526–530.
Agrawal A, Civantos FJ, Brumund KT, et al. [(99m)Tc]tilmanocept accurately detects sentinel lymph nodes and predicts node pathology status in patients with oral squamous cell carcinoma of the head and neck: results of a phase III multi-institutional trial. Ann Surg Oncol. 2015;22:3708–3715.
Rietbergen D, Arias-Bouda Pereira L, van der Hage J, et al. Meet 99mTc-tilmanocept as next generation radiotracer with the requirements for improved sentinel node imaging?Eur J Nucl Med Mol Imaging. 2019;46:S340.
Vidal-Sicart S, van Leeuwen FWB, van den Berg NS, et al. Fluorescent radiocolloids: are hybrid tracers the future for lymphatic mapping?Eur J Nucl Med Mol Imaging. 2015;42:1627–1630.
Bugby SL, Lees JE, Perkins AC. Hybrid intraoperative imaging techniques in radioguided surgery: present clinical applications and future outlook. Clin Transl Imaging. 2017;5:323–341.
Brouwer ORJ, Buckle T, Vermeeren L, et al. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification using lymphoscintigraphy and SPECT/CT. J Nucl Med. 2012;53:1034–1040.
KleinJan GH, van Werkhoven E, van den Berg NS, et al. The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodes. Eur J Nucl Med Mol Imaging. 2018;45:1915–1925.
Giammarile F, Schilling C, Gnanasegaran G, et al. The EANM practical guidelines for sentinel lymph node localization in oral cavity squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2019;46:623–637.
Schilling C, Stoeckli SJ, Vigili MG, et al. Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancer. Head Neck. 2019;41:2655–2664.
Chand M, Keller DS, Devoto L, et al. Furthering precision in sentinel node navigational surgery for oral cancer: a novel triple targeting system. J Fluoresc. 2018;28:483–486.
Van der Ploeg IM, Madu MF, van der Hage JA, et al. Blue dye can be safely omitted in most sentinel node procedures for melanoma. Melanoma Res. 2016;26:464–468.
Leong SP, Wu M, Lu Y, et al. Intraoperative imaging with a portable gamma camera may reduce the false-negative rate for melanoma sentinel node surgery. Ann Surg Oncol. 2018;25:3326–3333.
Meinhardt W, van der Poel HG, Valdés Olmos RA, et al. Laparoscopic sentinel lymph node biopsy for prostate cancer: the relevance of locations outside the extended dissection area. Prostate Cancer. 2012;2012:751753.
Martínez-Sarmiento M, Pérez-Ardavin J, Montserrat-Monfort JJ, et al. Sentinel lymph node biopsy in prostate cancer. Arch Esp Urol. 2019;72:842–850.
Wang XJ, Fang F, Li YF. Sentinel-lymph node procedures in early stage cervical cancer: a systematic review and meta-analysis. Med Oncol. 2015;32:385.
Van der Poel HG, Wit EM, Acar C, et al. Sentinel node biopsy for prostate cancer: report from a consensus panel meeting. BJU Int. 2017;120:204–211.
Van Oosterom MN, Simon H, Mengus L, et al. Revolutionizing (robot-assisted) laparoscopic gamma tracing using a DROP-IN gamma probe technology. Am J Nucl Med Mol Imaging. 2016;6:1–17.
Meershoek P, van Oosterom MN, Simon H, et al. Robot-assisted laparoscopic surgery using DROP-IN radioguidance: first-in-human transition. Eur J Nucl Med Mol Imaging. 2019;46:49–53.
Van Leeuwen FWB, van Oosterom MN, Meershoek P, et al. Minimal-invasive robot-assisted image-guided resection of prostate-specific membrane antigen–positive lymph nodes in recurrent prostate cancer. Clin Nucl Med. 2019;44:580–581.
Heil J, Kuerer HM, Pfob A, et al. Eliminating the breast cancer surgery paradigms after neoadjuvant systemic therapy: current evidence and future challenges. Ann Oncol. 2020;31:61–71.
Sener SF. Advances in axillary surgery for breast cancer 2019. J Surg Oncol. 2020;121:20–24.
Koolen BB, Donker M, Straver ME, et al. Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neo-adjuvant therapy. Br J Surg. 2017;104:1188–1196.
Van der Noordaa MEM, van Duijnhoven FH, Straver ME, et al. Major reduction in axillary lymph node dissections after neoadjuvant systemic therapy for node positive breast cancer by combining PET/CT and the MARI procedure. Ann Surg Oncol. 2018;25:1512–1520.
Simons JM, van Nijnatten TJA, van der Pool CC, et al. Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis. Ann Surg. 2019;269:432–442.
Hinsenveld FJ, Wit EWK, van Leeuwen PJ, et al. Prostate-specific membrane antigen PET/CT combined with sentinel node biopsy for primary lymph node staging in prostate cancer. J Nucl Med. 2020;61:540–545.
Guckenberger M, Lievens Y, Bouma AB, et al. Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol. 2020;21:e18–e28.
Maurer T, Robu S, Schottelius M, et al. 99mTechnetium-based prostate-specific membrane antigen–radioguided surgery in recurrent prostate cancer. Eur Urol. 2019;75:659–666.
Van Leeuwen FWB, Winter A, van der Poel HG, et al. Technologies for image-guided surgery for managing lymphatic metastases in prostate cancer. Nat Rev Urol. 2019;16:159–171.
Collarino A, Olmos RAV, Neijenhuis PA, et al. First clinical experience using stereotactic breast biopsy guided by 99mTc-sestamibi. AJR Am J Roentgenol. 2017;209:1367–1373.
Olde Heuvel J, de Wit-van der Veen BJ, van der Poel HG, et al. 68Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series [published online April 2, 2020]. Eur J Nucl Med Mol Imaging. 2020.
El Lakis M, Gianakou A, Nockel P, et al. Radioguided surgery with gallium 68 DOTATATE for patients with neuroendocrine tumors. JAMA Surg. 2019;154:40–45.
Hassing CMS, Tvedskov TF, Kroman N, et al. Radioactive seed localisation of non-palpable lymph nodes. A feasibility study. Eur J Surg Oncol. 2018;44:725–730.